- €68.82m
- €69.27m
- €59.73m
- 60
- 25
- 75
- 52
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 33.6 | 40 | 40.4 | 51.5 | 59.7 |
Cost of Revenue | |||||
Gross Profit | 13.8 | 26.7 | 27.3 | 34.7 | 40.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 33.3 | 40.9 | 43 | 54.1 | 57.4 |
Operating Profit | 0.297 | -0.885 | -2.57 | -2.57 | 2.35 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.047 | -0.963 | -2.92 | -2.36 | 1.74 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.06 | -2.86 | -4.02 | -3.28 | -0.293 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.06 | -2.86 | -4.02 | -3.28 | -0.293 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.06 | -2.86 | -4.02 | -3.28 | -0.292 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.132 | -0.327 | -0.408 | -0.186 | -0.004 |
Dividends per Share | |||||
Special Dividends per Share |